Efficacy evaluation of heat-sensitive moxibustion for chemotherapy symptoms of large intestine cancer

OBJECTIVE: To analyze and evaluate the clinical efficacy of heat‐sensitive moxibustion for symptoms of large intestine cancer. METHODS: Sixty patients with large intestine cancer were randomly divided into an observation group and a control group, 30 cases in each one. FOLFOX chemotherapy regimen was used in the two groups,and heat‐sensitive moxibustion was added in the observation group. The acupoints were Zusanli(ST 36), Sanyinjiao (SP 6) Xuehai (SP 10) and Geshu (BL 17), etc. The treatment was applied once a day,five‐day treatment as one course. Four courses were required. The reaction rates of uncomfortable symptoms by the Chinese version of the M. D. Anderson symptom inventory (MDASI‐C) scale and clinical effects were analyzed and evaluated in the two groups. RESULTS: After treatment, the MDASI‐C reaction rate of uncomfortable symptoms in the observation group was 50.4% which was lower than 53.3% in the control group (P < 0.05). The total effective rate of symptom improvement in the observation group was 83.3% (25/30), which was higher than 60.0% (18/30) in the control group (P < 0.05). CONCLUSION: Heat‐sensitive moxibustion can improve symptoms of chemotherapy for large intestine cancer.